95 related articles for article (PubMed ID: 24080855)
1. The EFEMP1 gene: a frequent target for epigenetic silencing in multiple human pituitary adenoma subtypes.
Duong CV; Yacqub-Usman K; Emes RD; Clayton RN; Farrell WE
Neuroendocrinology; 2013; 98(3):200-11. PubMed ID: 24080855
[TBL] [Abstract][Full Text] [Related]
2. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
3. Epigenomic silencing of the BMP-4 gene in pituitary adenomas: a potential target for epidrug-induced re-expression.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2012 Aug; 153(8):3603-12. PubMed ID: 22700770
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics of pituitary tumours: an update.
Farrell WE
Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):299-305. PubMed ID: 24983395
[TBL] [Abstract][Full Text] [Related]
5. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2013 May; 154(5):1711-21. PubMed ID: 23539512
[TBL] [Abstract][Full Text] [Related]
6. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer.
Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ
Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
[TBL] [Abstract][Full Text] [Related]
8. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a novel pituitary tumor apoptosis gene.
Bahar A; Simpson DJ; Cutty SJ; Bicknell JE; Hoban PR; Holley S; Mourtada-Maarabouni M; Williams GT; Clayton RN; Farrell WE
Mol Endocrinol; 2004 Jul; 18(7):1827-39. PubMed ID: 15105437
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of dually targeting gene therapy system for pituitary adenomas].
Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489
[TBL] [Abstract][Full Text] [Related]
11. Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas.
Duong CV; Emes RD; Wessely F; Yacqub-Usman K; Clayton RN; Farrell WE
Endocr Relat Cancer; 2012 Dec; 19(6):805-16. PubMed ID: 23045325
[TBL] [Abstract][Full Text] [Related]
12. Pituitary tumours: all silent on the epigenetics front.
Dudley KJ; Revill K; Clayton RN; Farrell WE
J Mol Endocrinol; 2009 Jun; 42(6):461-8. PubMed ID: 19208779
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms of tumorigenesis.
Farrell WE
Horm Metab Res; 2005 Jun; 37(6):361-8. PubMed ID: 16001328
[TBL] [Abstract][Full Text] [Related]
15. A novel apoptosis gene identified in the pituitary gland.
Farrell WE
Neuroendocrinology; 2006; 84(4):217-21. PubMed ID: 17135715
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
17. Histone acetylation patterns of typical and atypical pituitary adenomas indicate epigenetic shift of these tumours.
Ebrahimi A; Schittenhelm J; Honegger J; Schluesener HJ
J Neuroendocrinol; 2011 Jun; 23(6):525-30. PubMed ID: 21453398
[TBL] [Abstract][Full Text] [Related]
18. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
[TBL] [Abstract][Full Text] [Related]
19. [EFEMP1 suppresses growth and invasion of lung cancer cells
by downregulating matrix metalloproteinase-7 expression].
Lang Y; Meng J; Song X; Chen X
Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):92-7. PubMed ID: 25676403
[TBL] [Abstract][Full Text] [Related]
20. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
